Surveillance programs for stage I nonseminomatous germ cell tumors of the testis (Q36369288)

13 August 2017

1 reference

title

Surveillance programs for stage I nonseminomatous germ cell tumors of the testis (English)

1 reference

13 August 2017

Roanne Segal

1

1 reference

13 August 2017

publication date

1 January 2006

1 reference

13 August 2017

1 reference

13 August 2017

volume

24

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

68-74

1 reference

Surveillance alone for patients with clinical stage I nonseminomatous germ cell tumors of the testis: preliminary results

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Selected experience with surgery and combination chemotherapy in the treatment of nonseminomatous testis tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Active surveillance after orchiectomy for nonseminomatous testicular germ cell tumors: late relapse may occur

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Results of the surveillance policy of stage I non-seminomatous germ cell testicular tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single-center 10-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Surveillance in patients with stage I testicular nonseminomatous germ cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-year followup

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Orchiectomy alone for clinical stage I nonseminomatous germ cell tumors of the testis (NSGCTT): a minimum follow-up period of 5 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Surveillance for stage I non-seminomatous germ cell tumours of the testis: the optimal protocol has not yet been defined

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Surveillance alone versus radiotherapy after orchiectomy for clinical stage I nonseminomatous testicular cancer. Danish Testicular Cancer Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Surveillance after orchidectomy for patients with clinical stage I nonseminomatous testis tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Treatment of stage I testicular tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Surveillance study for clinical stage I testicular seminomas and nonseminomatous germ cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Surveillance can be the standard of care for stage I nonseminomatous testicular tumors and even high risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Follow-up of clinical stage I testicular cancer patients: cost and risk benefit considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Risk factors for relapse in stage I non-seminomatous germ-cell tumors: preliminary results of the German Multicenter Trial. German Testicular Cancer Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Stage I nonseminomatous germ cell testicular tumor: prediction of metastatic potential by primary histopathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Late results of surveillance of clinical stage I nonseminoma germ cell testicular tumours: 17 years' experience in a national study in New Zealand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

Histopathological features in stage I non-seminomatous testicular germ cell tumours correlated to relapse. Danish Testicular Cancer Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.07.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UROLONC.2005.07.006

1 reference

13 August 2017

1 reference